EUTM file information

018189446

Amyloid MS


January 28, 2020

Trademark Summary

The trademark application Amyloid MS was filed by Shimadzu Corporation, a corporation established under the laws of Japan (the "Applicant"). Application withdrawn.

The application was filed in English (Spanish was selected as the second language).

The Refusal with reference B 018189446 was Rejected according to Article 7(1)(b) EUTMR with decision issued on November 16, 2020 by the EUIPO.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals for research purposes, namely, chemicals for use in biochemistry or for use in molecular biology
    2. Chemical reagents for research purposes, namely, chemicals for use in biochemistry or for use in molecular biology
    3. Diagnostic reagents for scientific use
    4. Any of aforesaid goods other than for medical or veterinary purposes.
  • The mark was filed in class 9 with following description of goods:
    1. Scientific and laboratory apparatus and instruments including parts therefor, namely, gas-liquid separator for use in fluid chromatograph
    2. Optical instruments for use in biochemistry
    3. Measuring or testing machines and instruments for use in blood Analysis
    4. Telecommunication machines and apparatus for use in Biochemistry
    5. Electronic machines, apparatus and their parts for use in biochemistry.
  • The mark was filed in class 10 with Medical apparatus and instruments, namely, apparatus for blood analysis, medical diagnostic apparatus by analyzing body fluids and medical diagnostic apparatus for use in principal component analysis in biology by analysing body fluids and vitro diagnostic medical apparatus in the nature of mass spectrometers used in medical facilities..
  • The mark was filed in class 44 with following description of goods:
    1. Medical diagnostic testing services
    2. Medical analysis for medical treatment and medical diagnostic
    3. Body fluids analyzing services for Clinical examination.